Published in J Biocommun on January 01, 1990
Artificial neural networks can distinguish novice and expert strategies during complex problem solving. J Am Med Inform Assoc (1996) 1.04
Artificial neural network comparison of expert and novice problem-solving strategies. Proc Annu Symp Comput Appl Med Care (1994) 0.82
AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci U S A (1990) 2.79
Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization. J Immunol (1979) 2.38
Presence of infectious polyadenylated RNA in coronavirus avian bronchitis virus. Virology (1977) 2.19
Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization. J Clin Invest (1978) 1.70
Subpopulations of circulating B cells and regulatory T cells involved in in vitro immunoglobulin E production in atopic patients with elevted serum immunoglobulin E. J Clin Invest (1980) 1.68
Total and specific IgE (house dust mite and intestinal helminths) in asthmatics and controls from Gondar, Ethiopia. Clin Exp Allergy (2000) 1.65
Stimulation and regulation of human IgE production in vitro using peripheral blood lymphocytes. Clin Immunol Immunopathol (1979) 1.64
T-lymphocyte variant of hairy-cell leukemia. Ann Intern Med (1978) 1.56
Specific IgG mRNA molecules from myeloma cells in heterogeneous nuclear and cytoplasmic RNA containing poly-A. Nature (1972) 1.51
Immunologic characterization of hairy cell leukemias in continuous culture. J Immunol (1978) 1.47
Superoxide lon as the cause of the oxygen effect. Radiat Res (1976) 1.39
Identification of Actinobacillus actinomycetemcomitans: polymerase chain reaction amplification of lktA-specific sequences. Oral Microbiol Immunol (1993) 1.38
Glucocorticoids administered in vivo inhibit human suppressor T lymphocyte function and diminish B lymphocyte responsiveness in in vitro immunoglobulin synthesis. J Clin Invest (1978) 1.37
Estradiol radioimmunoassay without chromatography: procedure, validation and normal values. J Clin Endocrinol Metab (1974) 1.36
NK and T cell subsets regulate antibody production by human in vivo antigen-induced lymphoblastoid B cells. J Immunol (1984) 1.34
Differential synthesis of IgM and IgA anti-tetanus toxoid antibody in vitro following in vivo booster immunization of humans. Cell Immunol (1979) 1.17
Immunoglobulin-bearing cells are a target for the antigen-induced inhibition of pokeweed mitogen-stimulated antibody production. J Immunol (1981) 1.16
Detection of a fibroblast proliferation inhibitory factor from Capnocytophaga sputigena. Infect Immun (1980) 1.14
Evidence that pokeweed-mitogen-reactive B cells are pre-committed in vivo to the high-rate secretion of a single immunoglobulin isotype in vitro. Scand J Immunol (1981) 1.14
Suppression of immunoglobulin production in normal human blood: characterization of the cells responsible and mediation by a soluble T lymphocyte-derived factor. Clin Immunol Immunopathol (1978) 1.12
Protein kinase translocation as an early event in the hormonal control of uterine contraction. Science (1974) 1.09
Reduced in vitro production of anti-tetanus toxoid antibody after repeated in vivo immunization with tetanus toxoid. J Immunol (1979) 1.09
In vitro regulation of B cell differentiation by interleukin-6 and soluble CD23 in systemic lupus erythematosus B cell subpopulations and antigen-induced normal B cells. Arthritis Rheum (1991) 1.08
Conjugal transfer of broad-host-range incompatibility group P and Q plasmids from Escherichia coli to Actinobacillus actinomycetemcomitans. Infect Immun (1993) 1.05
Impaired immunoglobulin M synthesis by peripheral blood lymphocytes in systemic lupus erythematosus: a primary B-cell defect. Clin Immunol Immunopathol (1981) 1.04
Isotype-specific human B lymphocytes that produce immunoglobulin E in vitro when stimulated by pokeweed mitogen. J Allergy Clin Immunol (1980) 1.03
In vitro analysis of humoral immunity in antibody deficiency with normal immunoglobulins. Clin Immunol Immunopathol (1980) 1.03
The production of a soluble human T-lymphocyte derived factor which substitutes for helper T lymphocytes in the in vitro production of immunoglobulin. Immunology (1979) 1.02
RNA metabolism in HeLa cells at reduced temperature. I. Modified processing of 45S RNA. J Cell Biol (1971) 1.02
Biological and chemical characterization of endotoxin from Capnocytophaga sputigena. Infect Immun (1980) 1.02
Cytotoxicity of the bacterium Actinobacillus actinomycetemcomitans extracts in human gingival fibroblasts. Arch Oral Biol (1983) 0.98
Severe combined immunodeficiency with B lymphocytes: in vitro correction of defective immunoglobulin production by addition of normal T lymphocytes. Clin Exp Immunol (1976) 0.98
Immunoglobulin heavy chain mRNA in mitogen-stimulated B cells. Eur J Immunol (1975) 0.98
Evaluation of the antimicrobial potential of calcium hydroxide as an intracanal medicament. J Endod (1983) 0.97
Profile of multiple lymphocyte functional defects in acquired hypogrammaglobulinemia, derived from in vitro cell recombination analysis. J Allergy Clin Immunol (1980) 0.97
Isolation of messenger RNA coding for mouse heavy-chain immunoglobulin. Proc Natl Acad Sci U S A (1973) 0.97
Translational control of immunoglobulin synthesis. I. Repression of heavy chain synthesis. J Mol Biol (1973) 0.96
Characterization of an inducible bacteriophage from a leukotoxic strain of Actinobacillus actinomycetemcomitans. Infect Immun (1982) 0.95
Anti-Fab antibodies in humans. Predominance of minor immunoglobulin G subclasses in rheumatoid arthritis. J Clin Invest (1985) 0.93
Immunoglobulin synthesis in hairy cell leukaemia. Br J Haematol (1977) 0.93
Analysis of human anti-diphtheria antibodies by isoelectric focusing: evidence for restricted clonal heterogeneity of anti-fragment A antibodies. Infect Immun (1981) 0.93
Success of active tuberculosis case detection among high-risk groups in urban slums in Pakistan. Int J Tuberc Lung Dis (2014) 0.93
Isolation of nuclear pre-mRNA which codes for immunoglobulin heavy chain. Nat New Biol (1973) 0.93
War in Tajikistan and re-emergence of Plasmodium falciparum. Lancet (1998) 0.92
Translational control of immunoglobulin synthesis. II. Cell-free interaction of myeloma immunoglobulin with mRNA. J Mol Biol (1973) 0.92
Antigen-induced suppression of human in vitro pokeweed mitogen-stimulated antibody production. Cell Immunol (1980) 0.91
Group and type antigens of Capnocytophaga. Infect Immun (1979) 0.91
Multiple subsets of anti-tetanus toxoid antibody-producing cells in human peripheral blood differ by size, expression of membrane receptors, and mitogen reactivity. J Immunol (1981) 0.91
Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in induction of IgE. J Allergy Clin Immunol (1990) 0.90
A bacteriocin of Actinobacillus actinomycetemcomitans. Infect Immun (1987) 0.90
Anti-human helper T-lymphocyte antiserum: generation and functional characterization. Clin Immunol Immunopathol (1978) 0.89
Human in vivo antigen-induced lymphoblastoid B cells are capable of cyclical antibody production in vitro. J Immunol (1984) 0.88
Oncofetal protein accompanying irradiation-induced small-bowel adenocarcinoma in the rat. J Natl Cancer Inst (1975) 0.88
Clonally restricted anti-IgG antibodies in rheumatoid arthritis. Arthritis Rheum (1984) 0.88
Antibody potential of human peripheral blood lymphocytes differentially expressing surface membrane IgM. J Immunol (1980) 0.88
Inhibition of human antigen-induced lymphoblastoid B-cell function by an in vivo-induced suppressor T cell. Cell Immunol (1983) 0.87
Superoxide dismutase activity of Ehrlich ascites tumor cells. J Natl Cancer Inst (1977) 0.87
Inability of patients with common variable hypogammaglobulinemia to generate lymphjoblastoid B cells following booster immunization. Clin Immunol Immunopathol (1980) 0.86
Isolation of viruses from stools in stem cell transplant recipients: a prospective surveillance study. Bone Marrow Transplant (2000) 0.86
Abnormal B cell differentiation and variable increased T cell suppression in immunodeficiency with hyper-IgM. Clin Exp Immunol (1980) 0.86
Helper and suppressor t-lymphocyte leukemia in ataxia telangiectasia. N Engl J Med (1979) 0.86
An autoradiographic technique to evaluate in vitro produced autoantibodies by peripheral blood leucocytes of patients with bullous pemphigoid. Arch Dermatol Res (1983) 0.86
Defective memory B cell formation in patients with inflammatory bowel disease following tetanus toxoid booster immunization. J Clin Lab Immunol (1987) 0.86
Problems in biocontainment. Natl Cancer Inst Monogr (1966) 0.85
Lymphocyte dysfunction in chronic graft-versus-host disease. Blood (1981) 0.85
Immunoregulatory T cells in men with a new acquired immunodeficiency syndrome. J Clin Immunol (1983) 0.85
Interleukin 6 is essential for antibody secretion by human in vivo antigen-induced lymphoblastoid B cells. Cell Immunol (1990) 0.85
Suppression of immunoglobulin production in normal human B lymphocytes by two T-cell subsets distinguished following in vitro treatment with adenosine. Clin Immunol Immunopathol (1980) 0.85
Macroglobulinemia and hairy-cell leukemia. N Engl J Med (1977) 0.85
Lymphocyte cytotoxicity in the X-irradiation induced rat small bowel adenocarcinoma. II. Presence of cytotoxic lymphocytes in irradiated animals. Immunol Commun (1978) 0.85
Lymphocyte cytotoxicity in X-irradiation induced rat small bowel adenocarcinoma. IV. Activation of cellular immunity by X irradiation. Radiology (1979) 0.84
Dual immune defects in nongranulomatous ulcerative jejunoileitis with hypogammaglobulinemia. Clin Immunol Immunopathol (1977) 0.82
Superoxide dismutase activity in 1,2-dimethylhydrazine-induced rat colon adenocarcinoma. J Natl Cancer Inst (1980) 0.81
Identification and characterization of a circulating tumor-associated oncofetal protein from a radiation-induced adenocarcinoma of the rat small bowel. Cancer Res (1976) 0.81
Cyclic nucleotide concentrations in 7.12-dimethylbenz[a]anthracene-induced pancreatic cancer in rats. J Natl Cancer Inst (1978) 0.81
The selective role of membrane IgG in the antigen-induced inhibition of human in vitro antibody synthesis. J Immunol (1982) 0.81
Normal T cell regulation of IgG synthesis in systemic lupus erythematosus. J Clin Lab Immunol (1980) 0.81
Retinoblastoma Y79 cell line: a study of membrane structures. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1979) 0.80
Expression of surface membrane IgG on pokeweed mitogen-reactive anti-tetanus toxoid antibody-producing cells. J Clin Immunol (1981) 0.80
Human lung tumor-associated antigens of 32,000 daltons molecular weight. J Natl Cancer Inst (1979) 0.80
Human IgG anti-F(ab')2 antibodies possess rheumatoid factor activity. Clin Exp Immunol (1990) 0.80
Adenosine receptor lymphocytes in humoral immunodeficiency. J Clin Immunol (1981) 0.79
Lymphocyte cytotoxicity in X-irradiation-induced adenocarcinoma of the rat small bowel. I. Measurement of target cell destruction by release of radioiodinated membrane proteins: brief communication. J Natl Cancer Inst (1977) 0.79
Human adenosine receptor bearing lymphocytes: enumeration, characterization, and distribution in peripheral blood lymphocytes. Clin Immunol Immunopathol (1981) 0.79
Involvement of the transferrin receptor in the production and NK-induced suppression of human antibody synthesis. J Immunol (1984) 0.79
Subclasses of human IgG anti-Fab antibodies: parameters for optimum detection. Int Arch Allergy Appl Immunol (1985) 0.79
Human T lymphocyte-derived helper factor (HHF): cellular and physical characterization. Clin Immunol Immunopathol (1979) 0.79
Phenotypic heterogeneity in X-linked infantile agammaglobulinemia with in vitro monocyte suppression of immunoglobulin synthesis. Clin Immunol Immunopathol (1981) 0.79
Recognition by anti-Fab antibodies in rheumatoid arthritis of structure(s) widely distributed on human Fab molecules. Scand J Immunol (1988) 0.79
Genetic modifications to temperate Enterococcus faecalis phage Ef11 that abolish the establishment of lysogeny and sensitivity to repressor, and increase host range and productivity of lytic infection. Microbiology (2013) 0.79
Lymphocyte cytotoxicity in x-irradiation-induced rat small bowel adenocarcinoma. III. Blocking by 3 M KCL extract. J Immunol (1978) 0.79
Purification and biochemical properties of a bacteriocin from Actinobacillus actinomycetemcomitans. Infect Immun (1987) 0.79
T suppressor cells are required for the maintenance of the antigen-induced B-cell unresponsive state in humans. J Clin Immunol (1983) 0.78
Chemical-and X-ray-induced antitumor cell-mediated immunity to rat fetal cells. Oncodev Biol Med (1982) 0.78
Impaired generation of spontaneous and mitogen-reactive antitetanus toxoid antibody-producing B cells following repetitive in vivo booster immunization. Cell Immunol (1981) 0.78
Streptococcus mutans serotypes in caries-resistant and caries-susceptible adults. J Dent Res (1977) 0.78
Identification of a common oncofoetal protein in x-ray and chemically induced rat gastrointestinal tumours. Br J Cancer (1981) 0.78
Cyclic nucleotide concentrations in 1,2-dimethylhydrazine and x-ray induced rat small intestinal cancer. Cancer Lett (1978) 0.77
Adenosine 3',5'-cyclic monophosphate levels in x-ray-induced small-bowel adenocarcinoma in the rat. J Natl Cancer Inst (1976) 0.77